BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14581275)

  • 21. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
    Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B
    Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
    Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
    J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
    Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
    J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
    Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
    Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiol redox modulation of tumor necrosis factor-alpha responsiveness in cultured AIDS-related Kaposi's sarcoma cells.
    Mallery SR; Landwehr DJ; Ness GM; Clark YM; Hohl CM
    J Cell Biochem; 1998 Mar; 68(3):339-54. PubMed ID: 9518260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
    Broccolo F; Tassan Din C; Viganò MG; Rutigliano T; Esposito S; Lusso P; Tambussi G; Malnati MS
    J Clin Virol; 2016 May; 78():47-52. PubMed ID: 26985593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
    Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
    J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
    Murakami-Mori K; Mori S; Nakamura S
    J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of classical type Kaposi's sarcoma with paclitaxel.
    Chao SC; Lee JY; Tsao CJ
    Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
    Arastéh K; Hannah A
    Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.
    Bower M; Dalla Pria A; Coyle C; Andrews E; Tittle V; Dhoot S; Nelson M
    J Clin Oncol; 2014 Feb; 32(5):409-14. PubMed ID: 24378415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS).
    Bendle M; Pealing J; Papanastasopoulos P; Bower M
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):611-5. PubMed ID: 25055936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter.
    Faris M; Ensoli B; Kokot N; Nel AE
    AIDS; 1998 Jan; 12(1):19-27. PubMed ID: 9456251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
    Boivin G; Gaudreau A; Routy JP
    AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.